Leg amyotrophic diplegia: Prevalence and pattern of weakness at us neuromuscular centers

Mazen M. Dimachkie, Iryna M. Muzyka, Jonathan S. Katz, Carlayne Jackson, Yunxia Wang, April L. McVey, Arthur Dick, Mamatha Pasnoor, M. Tahseen Mozaffar, Z. Xiao-Song, John T. Kissel, Erik Ensrud, Jeffrey Rosenfeld, Richard J. Barohn

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective: To identify the frequency of leg amyotrophic diplegia (LAD) at a US academic center, describe the pattern of weakness, and provide comparative data from 8 additional major US academic institutions. BACKGROUND: LAD is a leg onset variant of progressive muscular atrophy (PMA). LAD weakness is confined to the legs for at least 2 years, and there are no upper motor neuron signs. DESIGN/Methods: We present a retrospective chart review of 24 patients with the LAD presentation from the University of Kansas Medical Center ( n = 8 cases) and from 8 US academic institutions (n = 16 cases). Results: Of the 318 subjects identified in the University of Kansas Medical Center Neuromuscular Research Database, 82% (260 subjects) had amyotrophic lateral sclerosis (ALS), 1.9% (6) had familial ALS, 6.6% (21) had primary lateral sclerosis, and 9.2% (29) had lower motor neuron (LMN) disease. Of these 29 cases, 16 had PMA, 5 had brachial amyotrophic diplegia, while 8 had LAD. The mean LAD age of onset was 58 years with a male/female ratio of 3/1. Onset was asymmetric in 7/8. We identified a pelviperoneal pattern of weakness (sparing of knee extension and/or ankle plantar flexion) in 4 cases and distal predominant weakness in 3 cases. All patients had electrodiagnostic findings consistent with motor neuron disease confined to the lower extremities. We present LAD disease duration and survival data from 8 major academic neuromuscular centers. At last follow-up, weakness progressed to involve the arms in 6/24 LAD cases and of these 6 cases, 2 patients died from progression to typical ALS. From onset of symptoms, mean survival in LAD is 87 months, with 92% of cases being alive. Conclusions/Relevance: The natural history of LAD differs from typical forms of ALS and PMA. LAD is a slowly progressive disorder that accounts for a fourth of LMN disease cases. An asymmetric pelviperoneal pattern of weakness should heighten the suspicion for LAD.

Original languageEnglish (US)
Pages (from-to)7-12
Number of pages6
JournalJournal of clinical neuromuscular disease
Volume15
Issue number1
DOIs
StatePublished - Sep 13 2013
Externally publishedYes

Fingerprint

Leg
Motor Neuron Disease
Spinal Muscular Atrophy
Amyotrophic Lateral Sclerosis
Arm
Survival
Motor Neurons
Natural History
Age of Onset
Ankle
Lower Extremity
Knee
Databases

Keywords

  • amyotrophic lateral sclerosis
  • leg amyotrophic diplegia
  • progressive motor dysfunction
  • progressive muscular atrophy

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Dimachkie, M. M., Muzyka, I. M., Katz, J. S., Jackson, C., Wang, Y., McVey, A. L., ... Barohn, R. J. (2013). Leg amyotrophic diplegia: Prevalence and pattern of weakness at us neuromuscular centers. Journal of clinical neuromuscular disease, 15(1), 7-12. https://doi.org/10.1097/CND.0b013e31829e22d1

Leg amyotrophic diplegia : Prevalence and pattern of weakness at us neuromuscular centers. / Dimachkie, Mazen M.; Muzyka, Iryna M.; Katz, Jonathan S.; Jackson, Carlayne; Wang, Yunxia; McVey, April L.; Dick, Arthur; Pasnoor, Mamatha; Mozaffar, M. Tahseen; Xiao-Song, Z.; Kissel, John T.; Ensrud, Erik; Rosenfeld, Jeffrey; Barohn, Richard J.

In: Journal of clinical neuromuscular disease, Vol. 15, No. 1, 13.09.2013, p. 7-12.

Research output: Contribution to journalArticle

Dimachkie, MM, Muzyka, IM, Katz, JS, Jackson, C, Wang, Y, McVey, AL, Dick, A, Pasnoor, M, Mozaffar, MT, Xiao-Song, Z, Kissel, JT, Ensrud, E, Rosenfeld, J & Barohn, RJ 2013, 'Leg amyotrophic diplegia: Prevalence and pattern of weakness at us neuromuscular centers', Journal of clinical neuromuscular disease, vol. 15, no. 1, pp. 7-12. https://doi.org/10.1097/CND.0b013e31829e22d1
Dimachkie, Mazen M. ; Muzyka, Iryna M. ; Katz, Jonathan S. ; Jackson, Carlayne ; Wang, Yunxia ; McVey, April L. ; Dick, Arthur ; Pasnoor, Mamatha ; Mozaffar, M. Tahseen ; Xiao-Song, Z. ; Kissel, John T. ; Ensrud, Erik ; Rosenfeld, Jeffrey ; Barohn, Richard J. / Leg amyotrophic diplegia : Prevalence and pattern of weakness at us neuromuscular centers. In: Journal of clinical neuromuscular disease. 2013 ; Vol. 15, No. 1. pp. 7-12.
@article{7510eb2c04f141a893e2e608cea82365,
title = "Leg amyotrophic diplegia: Prevalence and pattern of weakness at us neuromuscular centers",
abstract = "Objective: To identify the frequency of leg amyotrophic diplegia (LAD) at a US academic center, describe the pattern of weakness, and provide comparative data from 8 additional major US academic institutions. BACKGROUND: LAD is a leg onset variant of progressive muscular atrophy (PMA). LAD weakness is confined to the legs for at least 2 years, and there are no upper motor neuron signs. DESIGN/Methods: We present a retrospective chart review of 24 patients with the LAD presentation from the University of Kansas Medical Center ( n = 8 cases) and from 8 US academic institutions (n = 16 cases). Results: Of the 318 subjects identified in the University of Kansas Medical Center Neuromuscular Research Database, 82{\%} (260 subjects) had amyotrophic lateral sclerosis (ALS), 1.9{\%} (6) had familial ALS, 6.6{\%} (21) had primary lateral sclerosis, and 9.2{\%} (29) had lower motor neuron (LMN) disease. Of these 29 cases, 16 had PMA, 5 had brachial amyotrophic diplegia, while 8 had LAD. The mean LAD age of onset was 58 years with a male/female ratio of 3/1. Onset was asymmetric in 7/8. We identified a pelviperoneal pattern of weakness (sparing of knee extension and/or ankle plantar flexion) in 4 cases and distal predominant weakness in 3 cases. All patients had electrodiagnostic findings consistent with motor neuron disease confined to the lower extremities. We present LAD disease duration and survival data from 8 major academic neuromuscular centers. At last follow-up, weakness progressed to involve the arms in 6/24 LAD cases and of these 6 cases, 2 patients died from progression to typical ALS. From onset of symptoms, mean survival in LAD is 87 months, with 92{\%} of cases being alive. Conclusions/Relevance: The natural history of LAD differs from typical forms of ALS and PMA. LAD is a slowly progressive disorder that accounts for a fourth of LMN disease cases. An asymmetric pelviperoneal pattern of weakness should heighten the suspicion for LAD.",
keywords = "amyotrophic lateral sclerosis, leg amyotrophic diplegia, progressive motor dysfunction, progressive muscular atrophy",
author = "Dimachkie, {Mazen M.} and Muzyka, {Iryna M.} and Katz, {Jonathan S.} and Carlayne Jackson and Yunxia Wang and McVey, {April L.} and Arthur Dick and Mamatha Pasnoor and Mozaffar, {M. Tahseen} and Z. Xiao-Song and Kissel, {John T.} and Erik Ensrud and Jeffrey Rosenfeld and Barohn, {Richard J.}",
year = "2013",
month = "9",
day = "13",
doi = "10.1097/CND.0b013e31829e22d1",
language = "English (US)",
volume = "15",
pages = "7--12",
journal = "Journal of Clinical Neuromuscular Disease",
issn = "1522-0443",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Leg amyotrophic diplegia

T2 - Prevalence and pattern of weakness at us neuromuscular centers

AU - Dimachkie, Mazen M.

AU - Muzyka, Iryna M.

AU - Katz, Jonathan S.

AU - Jackson, Carlayne

AU - Wang, Yunxia

AU - McVey, April L.

AU - Dick, Arthur

AU - Pasnoor, Mamatha

AU - Mozaffar, M. Tahseen

AU - Xiao-Song, Z.

AU - Kissel, John T.

AU - Ensrud, Erik

AU - Rosenfeld, Jeffrey

AU - Barohn, Richard J.

PY - 2013/9/13

Y1 - 2013/9/13

N2 - Objective: To identify the frequency of leg amyotrophic diplegia (LAD) at a US academic center, describe the pattern of weakness, and provide comparative data from 8 additional major US academic institutions. BACKGROUND: LAD is a leg onset variant of progressive muscular atrophy (PMA). LAD weakness is confined to the legs for at least 2 years, and there are no upper motor neuron signs. DESIGN/Methods: We present a retrospective chart review of 24 patients with the LAD presentation from the University of Kansas Medical Center ( n = 8 cases) and from 8 US academic institutions (n = 16 cases). Results: Of the 318 subjects identified in the University of Kansas Medical Center Neuromuscular Research Database, 82% (260 subjects) had amyotrophic lateral sclerosis (ALS), 1.9% (6) had familial ALS, 6.6% (21) had primary lateral sclerosis, and 9.2% (29) had lower motor neuron (LMN) disease. Of these 29 cases, 16 had PMA, 5 had brachial amyotrophic diplegia, while 8 had LAD. The mean LAD age of onset was 58 years with a male/female ratio of 3/1. Onset was asymmetric in 7/8. We identified a pelviperoneal pattern of weakness (sparing of knee extension and/or ankle plantar flexion) in 4 cases and distal predominant weakness in 3 cases. All patients had electrodiagnostic findings consistent with motor neuron disease confined to the lower extremities. We present LAD disease duration and survival data from 8 major academic neuromuscular centers. At last follow-up, weakness progressed to involve the arms in 6/24 LAD cases and of these 6 cases, 2 patients died from progression to typical ALS. From onset of symptoms, mean survival in LAD is 87 months, with 92% of cases being alive. Conclusions/Relevance: The natural history of LAD differs from typical forms of ALS and PMA. LAD is a slowly progressive disorder that accounts for a fourth of LMN disease cases. An asymmetric pelviperoneal pattern of weakness should heighten the suspicion for LAD.

AB - Objective: To identify the frequency of leg amyotrophic diplegia (LAD) at a US academic center, describe the pattern of weakness, and provide comparative data from 8 additional major US academic institutions. BACKGROUND: LAD is a leg onset variant of progressive muscular atrophy (PMA). LAD weakness is confined to the legs for at least 2 years, and there are no upper motor neuron signs. DESIGN/Methods: We present a retrospective chart review of 24 patients with the LAD presentation from the University of Kansas Medical Center ( n = 8 cases) and from 8 US academic institutions (n = 16 cases). Results: Of the 318 subjects identified in the University of Kansas Medical Center Neuromuscular Research Database, 82% (260 subjects) had amyotrophic lateral sclerosis (ALS), 1.9% (6) had familial ALS, 6.6% (21) had primary lateral sclerosis, and 9.2% (29) had lower motor neuron (LMN) disease. Of these 29 cases, 16 had PMA, 5 had brachial amyotrophic diplegia, while 8 had LAD. The mean LAD age of onset was 58 years with a male/female ratio of 3/1. Onset was asymmetric in 7/8. We identified a pelviperoneal pattern of weakness (sparing of knee extension and/or ankle plantar flexion) in 4 cases and distal predominant weakness in 3 cases. All patients had electrodiagnostic findings consistent with motor neuron disease confined to the lower extremities. We present LAD disease duration and survival data from 8 major academic neuromuscular centers. At last follow-up, weakness progressed to involve the arms in 6/24 LAD cases and of these 6 cases, 2 patients died from progression to typical ALS. From onset of symptoms, mean survival in LAD is 87 months, with 92% of cases being alive. Conclusions/Relevance: The natural history of LAD differs from typical forms of ALS and PMA. LAD is a slowly progressive disorder that accounts for a fourth of LMN disease cases. An asymmetric pelviperoneal pattern of weakness should heighten the suspicion for LAD.

KW - amyotrophic lateral sclerosis

KW - leg amyotrophic diplegia

KW - progressive motor dysfunction

KW - progressive muscular atrophy

UR - http://www.scopus.com/inward/record.url?scp=84883616334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883616334&partnerID=8YFLogxK

U2 - 10.1097/CND.0b013e31829e22d1

DO - 10.1097/CND.0b013e31829e22d1

M3 - Article

C2 - 23965403

AN - SCOPUS:84883616334

VL - 15

SP - 7

EP - 12

JO - Journal of Clinical Neuromuscular Disease

JF - Journal of Clinical Neuromuscular Disease

SN - 1522-0443

IS - 1

ER -